Revlimid Side Effects
View Community-reported Revlimid side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Revlimid Side Effect
Have You dealt with a Revlimid side effect? Share your experience
Revlimid Side Effects summary
Total Revlimid reports: 5063.Revlimid FDA safety alerts: No.
Reported deaths: 1967 Reported hospitalizations: 1610.
Take Revlimid Side Effects Survey, Discuss Revlimid with others
Revlimid Side Effects: death, disease progression, multiple myeloma, malignant neoplasm progression, fatigue, myelodysplastic syndrome, platelet count decreased, asthenia, pancytopenia, thrombocytopenia, white blood cell count decreased,
Revlimid Usage.
If you have questions about Revlimid, you can ask a Health Expert or Ask Patient Community about Revlimid.
Revlimid Side Effects reported to FDA
Showing 1-40 of 5063 Next >
Revlimid Side Effects Report #5662859-XPhysician from UNITED STATES reported REVLIMID problem on Feb 27, 2008. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anorexia, coma, confusional state, diarrhoea. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5662862-X
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 29, 2008. Female patient, 71 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, febrile neutropenia. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 02/29/2008.
Revlimid Side Effects Report #5662863-1
Health Professional from UNITED STATES reported REVLIMID problem on Feb 28, 2008. Female patient was diagnosed with mantle cell lymphoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: angioedema. REVLIMID dosage: unknown. During the same period patient was treated with RITUXAN. Patient recovered.
Revlimid Side Effects Report #5662905-3
REVLIMID problem was reported by a Health Professional from UNITED STATES on Feb 26, 2008. Female patient, 75 years of age, was diagnosed with b-cell lymphoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: deafness unilateral, ear pain, glossodynia, localised infection, lymphadenopathy, malaise, neutropenia, oedema mouth, oral mucosal exfoliation. REVLIMID dosage: 25 MG, X 21 DAYS W/7 DAYS OFF, ORAL. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5663204-6
Physician from UNITED STATES reported REVLIMID problem on Mar 03, 2008. Male patient, 79 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: dialysis, renal cyst, renal failure acute. REVLIMID dosage: 25 MG, DAILY, ORAL. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5663322-2
REVLIMID problem was reported by a Health Professional from UNITED STATES on Feb 28, 2008. Male patient, 83 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anorexia, condition aggravated, fatigue, hepatic function abnormal, multiple myeloma, vision blurred. REVLIMID dosage: X21 DAYS EVERY 28 DAYS, ORAL; 5MG - 20MG, ORAL;. Patient recovered.
Revlimid Side Effects Report #5663328-3
Health Professional from SPAIN reported REVLIMID problem on Feb 26, 2008. Male patient was diagnosed with 5q-syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anxiety, conjunctivitis, eye pruritus, haemoglobin decreased, hypoacusis, lacrimation increased, neutrophil count decreased, periorbital oedema, platelet count decreased. REVLIMID dosage: 10 MG, EVERY 48 HOURS, ORAL; 10 MG, EVERY 72 HOURS FOR 28 DAY CYCLE, ORAL. During the same period patient was treated with NEUPOGEN, ARANESP. Patient recovered.
Revlimid Side Effects Report #5663343-X
REVLIMID problem was reported by a Physician from FRANCE on Feb 27, 2008. Male patient, 56 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: gastritis, proctocolitis, rectal haemorrhage. REVLIMID dosage: 25 MG, DAILY, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5663385-4
Physician from UNITED STATES reported REVLIMID problem on Mar 03, 2008. Female patient, 50 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 12/01/2007.
Revlimid Side Effects Report #5663687-1
REVLIMID problem was reported by a Pharmacist from FRANCE on Mar 03, 2008. Male patient, 76 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: accidental overdose, respiratory failure. REVLIMID dosage: 20 MG, DAILY, ORAL; 10 MG, DAILY X21 DAYS, ORAL. Patient died.
Revlimid Side Effects Report #5664800-2
Health Professional from UNITED STATES reported REVLIMID problem on Feb 29, 2008. Female patient was diagnosed with mantle cell lymphoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: diplopia, loss of consciousness, vertigo. REVLIMID dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient recovered.
Revlimid Side Effects Report #5664801-4
REVLIMID problem was reported by a Health Professional from UNITED STATES on Mar 05, 2008. Female patient, 59 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, liver function test abnormal, pulmonary embolism. REVLIMID dosage: 25 MG, DAILY FOR 21 DAYS, ORAL. During the same period patient was treated with DARBEPOETIN, ZOMETA. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5664803-8
Physician from UNITED STATES reported REVLIMID problem on Mar 05, 2008. Female patient, 85 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: fall, haematoma. REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 03/04/2008.
Revlimid Side Effects Report #5664804-X
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 04, 2008. Female patient, 64 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 01/15/2008.
Revlimid Side Effects Report #5664805-1
Health Professional from UNITED STATES reported REVLIMID problem on Feb 29, 2008. Male patient, 72 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: peritonitis. REVLIMID dosage: 25 MG, QD, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5668476-X
REVLIMID problem was reported by a Health Professional from UNITED STATES on Feb 29, 2008. Male patient, 76 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac enzymes increased, dyspnoea, rhabdomyolysis. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL, 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DEXAMETHASONE, AMOXICILLIN, ACYCLOVIR, ZOFRAN, MAXZIDE, LEVOTHROID, POTASSIUM. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5668489-8
Physician from UNITED STATES reported REVLIMID problem on Mar 03, 2008. Female patient, 66 years of age, was diagnosed with 5q-syndrome, anaemia, myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, chest discomfort, chronic inflammatory demyelinating polyradiculoneuropathy, csf glucose abnormal, csf protein increased, diarrhoea, dyspnoea. REVLIMID dosage: 10 MG, QD; ORAL, 5 MG, QD; ORAL. During the same period patient was treated with VALIUM, NEXIUM, VICODIN. Patient was hospitalized and became disabled. Patient recovered.
Revlimid Side Effects Report #5668529-6
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 05, 2008. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 02/01/2008.
Revlimid Side Effects Report #5668530-2
Physician from UNITED STATES reported REVLIMID problem on Mar 07, 2008. Female patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute leukaemia, diarrhoea, disease progression, myelodysplastic syndrome, purpura. REVLIMID dosage: 2.5 MG, 1 IN 2 D, ORAL, 5 MG, 1 IN 1 D, ORAL, 5 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5668558-2
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 03, 2008. Male patient, 86 years of age, was diagnosed with 5q-syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, disease progression, myelodysplastic syndrome. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 02/14/2008.
Revlimid Side Effects Report #5668559-4
Physician from UNITED STATES reported REVLIMID problem on Mar 06, 2008. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelodysplastic syndrome. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 02/16/2008.
Revlimid Side Effects Report #5668592-2
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 06, 2008. Male patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: pneumonia. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 02/17/2008.
Revlimid Side Effects Report #5668660-5
Physician from UNITED STATES reported REVLIMID problem on Feb 28, 2008. Male patient, 68 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, muscle atrophy, neuropathy peripheral, neutropenia, renal osteodystrophy, t-cell lymphoma, weight decreased. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5668661-7
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 06, 2008. Male patient, 47 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5668662-9
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Mar 04, 2008. Male patient, 63 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: asthenia, dyspnoea, fatigue. REVLIMID dosage: 5 MG, 1 IN 2 D, ORAL. During the same period patient was treated with COLESTIPOL, VITAMIN D, VITAMIN B12, POTASSIUM, THIAMINE, BRUMEX, LANTUS, NOVOLOG. Patient died on 01/01/2008.
Revlimid Side Effects Report #5668663-0
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 04, 2008. Male patient, 69 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute leukaemia. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL; 5 MG, 1 IN 1 D, ORAL. Patient died on 02/11/2008.
Revlimid Side Effects Report #5668664-2
Physician from UNITED STATES reported REVLIMID problem on Feb 29, 2008. Female patient, 35 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood human chorionic gonadotropin increased. REVLIMID dosage: 10 MG, DAILY, ORAL. Patient recovered.
Revlimid Side Effects Report #5668665-4
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 04, 2008. Female patient, 75 years of age, was diagnosed with acute myeloid leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, malignant neoplasm progression, pneumonia. REVLIMID dosage: 10 MG, QD, ORAL. During the same period patient was treated with ACYCLOVIR, CALCIUM, GABAPENTIN, LEUCOVORIN CALCIUM, PRILOSEC, VORICONAZOLE, OXYCONTIN, COMPAZINE. Patient was hospitalized. Patient died on 10/08/2007.
Revlimid Side Effects Report #5668666-6
Physician from UNITED STATES reported REVLIMID problem on Mar 05, 2008. Male patient, 75 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: fatigue, insomnia, myocardial infarction. REVLIMID dosage: unknown. Patient died on 02/06/2008.
Revlimid Side Effects Report #5668667-8
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 06, 2008. Male patient, 66 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 20 MG, 2 IN 1 D, ORAL. Patient died on 01/04/2008.
Revlimid Side Effects Report #5668687-3
Physician from GREECE reported REVLIMID problem on Mar 03, 2008. Female patient, 78 years of age, weighting 165.3 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anorexia, back pain, face oedema, pitting oedema. REVLIMID dosage: unknown. Patient recovered.
Revlimid Side Effects Report #5668688-5
REVLIMID problem was reported by a Health Professional from NETHERLANDS on Mar 06, 2008. Male patient, 70 years of age, weighting 121.3 lb, was diagnosed with disease progression and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anaemia, diarrhoea, haemorrhage, leukopenia, platelet count decreased, sepsis. REVLIMID dosage: 25 MG, ORAL. During the same period patient was treated with TEMAZEPAM, LOPERAMIDE. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5668692-7
Physician from NORWAY reported REVLIMID problem on Mar 04, 2008. Male patient, 65 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amnesia. REVLIMID dosage: 25 MG, EVERY OTHER DAY, ORAL, 25 MG, DAILY FROM DAY 10, ORAL. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Revlimid Side Effects Report #5670128-7
REVLIMID problem was reported by a Physician from GERMANY on Mar 05, 2008. Male patient, 59 years of age, weighting 154.3 lb, was diagnosed with plasmacytoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: embolism, ischaemia, retinal ischaemia. REVLIMID dosage: 25 MG, ORAL. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Revlimid Side Effects Report #5670180-9
Health Professional from UNITED KINGDOM reported REVLIMID problem on Feb 28, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: neurotoxicity. REVLIMID dosage: unknown. Patient recovered.
Revlimid Side Effects Report #5670190-1
REVLIMID problem was reported by a Physician from GERMANY on Mar 05, 2008. Male patient, 39 years of age, weighting 196.2 lb, was diagnosed with hodgkin's disease and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiovascular insufficiency, dialysis, diarrhoea, emphysema, haematocrit decreased, haemoglobin decreased, hepatic failure, hepatomegaly, klebsiella infection. REVLIMID dosage: 25 MG, DAILY, ORAL. During the same period patient was treated with PANTAZOL, DIFLUCAN, PREDNISOLONE, LINEZOLID. Patient was hospitalized. Patient died on 02/16/2008.
Revlimid Side Effects Report #5670193-7
Physician from SWITZERLAND reported REVLIMID problem on Mar 05, 2008. Female patient, 65 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, diarrhoea, disease progression, fall. REVLIMID dosage: 10 MG, EVERY SECOND DAY, ORAL. Patient died on 11/07/2007.
Revlimid Side Effects Report #5671213-6
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Mar 04, 2008. Female patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, flushing, pruritus, swelling face. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL; 12.5 MG, 1 IN 2 D, ORAL; 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DIPHENHYDRAMINE, DEXAMETHASONE. Patient recovered.
Revlimid Side Effects Report #5671222-7
Health Professional from UNITED STATES reported REVLIMID problem on Mar 05, 2008. Female patient, 85 years of age, weighting 143.5 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: confusional state, culture urine positive, cystitis, diverticulitis, fluid overload, haemoglobin decreased, headache, hypocalcaemia, hypokalaemia. REVLIMID dosage: 15 MG, QD, ORAL; 10 MG, ORAL; 25 MG, QD X21 DAYS, ORAL. During the same period patient was treated with DEXAMETHASONE, COUMADIN, BACTRIM DS, ASPIRIN. Patient was hospitalized. Patient died on 04/25/2007.
Revlimid Side Effects Report #5671223-9
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2008. Male patient, 63 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 03/05/2008.
Showing 1-40 of 5063 Next >